Vanguard Capital Management’s HeartSciences HSCS Stock Holding History
Bought
Maintained
Sold
Other funds holding HSCS
Vanguard Capital Management's HSCS Position: Q3 2026 in Review
Vanguard Capital Management increased its HeartSciences (HSCS) stake by 201% in Q3 2026, buying an estimated $109K and bringing the position to 54,113 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #3777.
Vanguard Capital Management first reported a position in HSCS in Q1 2026 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold HSCS as of Q3 2026.
- Vanguard Capital Management held 54,113 shares of HeartSciences worth $226K as of Q3 2026.
- Vanguard Capital Management bought 36,145 HeartSciences shares in Q3 2026, an estimated $109K.
- HeartSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3777 holding.
- Vanguard Capital Management first reported a position in HeartSciences in Q1 2026 and has held it in 3 quarters since.
- 18 funds tracked by Wall St. Rank held HeartSciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.